Rodman & Renshaw analyst Elemer Piros downgraded Cassava Sciences (NASDAQ: SAVA) from Buy to Sell with a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE